Characteristics, Outcomes, and Clinical Indicators of Bloodstream Infections in Neutropenic Patients with Hematological Malignancies: A 7-Year Retrospective Study

Characteristics, Outcomes, and Clinical Indicators of Bloodstream Infections in Neutropenic Patients with Hematological Malignancies: A 7-Year Retrospective Study

Shuyun Wang,1 Yan Song,1 Nan Shi,1,2 Donghong Yin,1 Jianbang Kang,1 Wanni Cai,2 Jinju Duan1 1Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China; 2Department of Pharmacy, School of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, Peo...

Full description

Bibliographic Details
Main Authors:	Wang S, Song Y, Shi N, Yin D, Kang J, Cai W, Duan J
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-07-01
Series:	Infection and Drug Resistance
Subjects:	bloodstream infection neutropenia hematological malignancy pathogens distribution antibiotic susceptibility risk factors.
Online Access:	https://www.dovepress.com/characteristics-outcomes-and-clinical-indicators-of-bloodstream-infect-peer-reviewed-fulltext-article-IDR

Similar Items

The Evaluation of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies
by: Kemalettin AYDIN, et al.
Published: (2007-06-01)

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
by: Alba Bergas, et al.
Published: (2022-06-01)

Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009–2019)
by: Halima El Omri, et al.
Published: (2024-01-01)

Epidemiology, resistant pathogens, and causes of early death in cases of bloodstream infection in patients with hematological malignancies from 2012–2019
by: Meng Li, et al.
Published: (2022-03-01)

Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease
by: Eun Young Nam, et al.
Published: (2016-03-01)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
by: Aslıhan Demirel, et al.
Published: (2015-07-01)

Evaluation of febrile neutropenic patients hospitalized in a hematology clinic
by: Mücahit Görük, et al.
Published: (2015-12-01)

High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic children with hematological diseases
by: Li-Peng Liu, et al.
Published: (2023-07-01)

Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
by: Müge ASLAN, et al.
Published: (2014-12-01)

PCR-based rapid identification of methicillin-resistant Staphylococcus aureus strains and their antibiotic resistance profiles in febrile neutropenic patients
by: Maggie Ibrahim, et al.
Published: (2023-11-01)

Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies
by: Jinjin Wang, et al.
Published: (2023-06-01)

Risk Prediction and Prognosis of Invasive Fungal Disease in Hematological Malignancies Patients Complicated with Bloodstream Infections
by: Xiao H, et al.
Published: (2020-03-01)

Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients
by: Kuntegowdanahalli C Lakshmaiah, et al.
Published: (2015-07-01)

Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
by: Meng H, et al.
Published: (2022-08-01)

A clinical analysis of Candida tropicalis bloodstream infections associated with hematological diseases, and antifungal susceptibility: a retrospective survey
by: Beibei Yang, et al.
Published: (2023-07-01)

Distribution of Bacteria Isolated from Febrile Neutropenic Cases and Their Antibiotic Susceptibilities
by: Serap GENÇER, et al.
Published: (2003-09-01)

EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA
by: Cumali Yalçın, et al.
Published: (2022-04-01)

A Visualized Mortality Prediction Score Model in Hematological Malignancies Patients with Carbapenem-Resistant Organisms Bloodstream Infection
by: Qian C, et al.
Published: (2023-01-01)

Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
by: Zhang P, et al.
Published: (2020-09-01)

Microbiological Profile and Antibiotic Resistance of Bloodstream Infections among Cancer Patients at a Tertiary Care Cancer Centre in North Kerala, India
by: PARTHIBAN RUDRAPATHY, et al.
Published: (2022-01-01)

Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy
by: Abi Manesh Sathya Kumar, et al.
Published: (2023-02-01)

Efficacy of an antimicrobial stewardship intervention for early adaptation of antibiotic therapy in high-risk neutropenic patients
by: Claire Durand, et al.
Published: (2024-01-01)

ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
by: Daniel Olson, et al.
Published: (2014-08-01)

Semi-nested polymerase chain reaction over blood culture in detection of bloodstream fungal infection in leukemic children with febrile neutropenia
by: Pradeep Paul, et al.
Published: (2020-01-01)

Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients
by: Thaís Guimarães, et al.
Published: (2022-09-01)

Gram-Negative Bacteria Bloodstream Infections in Patients with Hematological Malignancies – The Impact of Pathogen Type and Patterns of Antibiotic Resistance: A Retrospective Cohort Study
by: Tang Y, et al.
Published: (2021-08-01)

A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia
by: He N, et al.
Published: (2020-06-01)

Bundle Approach to Reduce Bloodstream Infections in Neutropenic Hematologic
by: Jose Manuel Martinez, et al.
Published: (2015-07-01)

TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY
by: Rola Husni, et al.
Published: (2021-04-01)

Alarming Antibiotic Resistance in Pediatric Oncology Patients: A Three-Year Prospective Cohort Study from Oman [Corrigendum]
by: Al Battashi A, et al.
Published: (2022-08-01)

Alarming Antibiotic Resistance in Pediatric Oncology Patients: A Three-Year Prospective Cohort Study from Oman
by: Al Battashi A, et al.
Published: (2022-07-01)

<i>Pseudomonas aeruginosa</i> Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors
by: Cristina Royo-Cebrecos, et al.
Published: (2022-09-01)

The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections
by: Lu L, et al.
Published: (2022-06-01)

Epidemiology of Febrile Neutropenia Episodes with Gram-Negative Bacteria Infection in Patients Who Have Undergone Chemotherapy for Hematologic Malignancies: A Retrospective Study of 10 Years’ Data from a Single Center
by: Zhang Y, et al.
Published: (2020-03-01)

Microbiological Profile of Blood Stream Infections in Febrile Neutropenic Patients at a Tertiary Care Teaching Hospital in Rishikesh, Uttarakhand
by: Manisha Paul, et al.
Published: (2020-08-01)

Detection of Legionella Pneumophila in Urine and Serum Specimens of Neutropenic Febrile Patients with Haematological Malignancies
by: Nastaran Farzi, et al.
Published: (2016-12-01)

Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience
by: Najmul Karim, et al.
Published: (2022-08-01)

Characteristics and Outcomes of Bloodstream Infections in a Tertiary-Care Pediatric Hematology–Oncology Unit: A 10-Year Study
by: Davide Mattei, et al.
Published: (2022-02-01)

Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study
by: Francesco Marchesi, et al.
Published: (2020-08-01)

Bloodstream Infections in Paediatric Cancer Patients with Febrile Neutropenia in a Tertiary Cancer Centre in North-East India
by: Amrita Talukdar, et al.
Published: (2023-10-01)